CER-001 identified as potential treatment for septic patients

A Phase II pilot study demonstrated CER-001 is a potentially game-changing treatment for septic patients at high risk of acute kidney injury.

Related Keywords

Italy ,Loreto Gesualdo ,Connie Peyrottes ,University Of Bari Aldo Moro ,Professor Loreto Gesualdo ,Transplantation Unit ,Bari Aldo Moro ,Kidney Disease ,Improving Global Outcomes ,High Density Lipoprotein ,